Serum Institute of India Pvt Ltd (SIIPL) has recently conducted a clinical trial of a recombinant BCG vaccine candidate, VPM1002 which has been supported under the Department of Biotechnology’s National Biopharma Mission.
About the BCG vaccine
About the Department of Biotechnology
About Biotechnology Industry Research Assistance Council (BIRAC)
About National Biopharma Mission
About Serum Institute of India Pvt Ltd (SIIPL)
Your email address will not be published. Required fields are marked *
© Powered By Current Hunt, Designed & Developed By Quizsolver.com
This function has been disabled for Current Hunt.